Sinovac Biotech, Ltd
SVA
SVA was delisted on the 22nd of February, 2019.
37 hedge funds and large institutions have $67.3M invested in Sinovac Biotech, Ltd in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 7 closing their positions.
1% more capital invested
Capital invested by funds: $66.5M → $67.3M (+$781K)
0% more funds holding
Funds holding: 37 → 37 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
0% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.73M |
| 2 |
First Manhattan
New York
|
+$2.27M |
| 3 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
+$1.62M |
| 4 |
Morgan Stanley
New York
|
+$774K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$393K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$3.02M |
| 2 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
-$944K |
| 3 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
-$814K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$255K |
| 5 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$159K |
SVA Hedge Fund Activity: Q3 2015 in Review
37 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Sinovac Biotech, Ltd (SVA) for Q3 2015, worth a combined $67.3M — up 1.2% from $66.5M a quarter earlier.
Fund positioning in SVA was balanced in Q3 2015: 7 funds opened new positions, 7 closed out, 11 added to existing stakes and 11 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $2.73M. The largest seller was Pine River Capital Management, cutting an estimated $3.02M.
- 37 institutional investors held Sinovac Biotech, Ltd (SVA) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $67.3M of Sinovac Biotech, Ltd stock for Q3 2015, up 1.2% quarter-over-quarter.
- 7 funds opened new Sinovac Biotech, Ltd positions in Q3 2015 and 7 closed out, a net change of 0 holders.
- The largest Sinovac Biotech, Ltd buyer in Q3 2015 was Wellington Management Group, an estimated $2.73M added.
- The largest Sinovac Biotech, Ltd seller in Q3 2015 was Pine River Capital Management, an estimated $3.02M sold.
Based on aggregated 13F filings for Q3 2015.